Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Unknown statusNCT03063697
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to Evaluate the Safety of DILATREND SR Cap. in Korean Patients with Essential hypertension, Chronic stable angina and Congestive heart failure for 52 weeks.
Study details
- Official title
- Prospective, Multi-center, Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
- Conditions
- Essential Hypertension
- Chronic Stable Angina
- Congestive Heart Failure
- Sponsor
- Chong Kun Dang Pharmaceutical
- Start date
- 2015-11
- Primary completion
- 2020-12
- Sex
- All
- Age range
- from 19 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age 19 years or older Patients with Essential hypertension, Chronic stable angina and Congestive heart failure 2. Possible to take Dilatrend SR on the label 3. not taking Caverdilol for 6 month from Agreement date 4. Agreement with written informed consent Exclusion Criteria: 1. Pregnancy or lactation 2. Known hypersensitivity to Carvedilol 3. Cardiogenic shock 4. Abnormality of the conduction system as Severe bradycardia(In particular, pulse \<50beats / min), 2nd degree AV block, Complete AV block, Sinus Block, Sick Sinus Syndrome 5. Cor pulmonale 6. IDDM with ketoacidosis, metabolic acidosis 7. has severe heart disease(Heart failure NYHA functional class 4) 8. Respiratory diseases as Asthma, Chronic Obstructive Pulmonary Disease 9. Secondary hypertension 10. Prinzmetal's angina 11. Acute pulmonary embolism 12. Pheochromocytoma 13. Take MAO lnhibitor(except for MAO-B) 14. Hypotension ( SBP 90mmHg or less) 15. Severe hepatic dysfunction 16. Peripheral circulatory disturbance( ex. Raynaud syndrome, intermittent claudication) 17. Has edema glottitis 18. Has heart attack with complication 19. Fluid retention or overload to required intravenous inotropes 20. Allergic rhinitis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03063697